MED-EL’s cochlear implants are now FDA-approved in children seven months and older with bilateral sensorineural hearing loss ...

An FDA study in two groups of children shows that MED-EL cochlear implants are safe and effective for children seven-71 months old with bilateral SNHL who cannot hear well enough with hearing aids.

Durham, NC – (July 9, 2008)– MED-EL Corporation announced today new data regarding FineHearingTM technology, available only with the MAESTRO™ Cochlear Implant System. In addition to hearing in "high ...

DURHAM, N.C.--(BUSINESS WIRE)--Hearing implant leader, MED-EL Corporation USA, today announced the launch of the world’s first single-unit processor for cochlear implants, the RONDO™. For the first ...

DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the new slim and lightweight RONDO 3 Audio Processor for the SYNCHRONY Cochlear ...

RESEARCH TRIANGLE PARK – MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of the Year” by the online publication Hearing Health ...

Patients with single-sided deafness or asymmetric hearing loss often have associated problems like identifying where sounds originate, maintaining balance, speech recognition and hearing in complex ...

Thirteen children with MED-EL cochlear implants explored the power of self-expression through photography during a three-week creative workshop organized by Canon in partnership with MED-EL, a global ...

MED-EL USA announced today that, together with Starkey, DualSync technology was awarded a Hearing Technology Innovator Award in the Bimodal Hearing Category. The annual awards program, hosted by ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...